MMRGlobal 2013 Chairman's Letter

MMRGlobal 2013 Chairman's Letter 
LOS ANGELES, CA -- (Marketwire) -- 01/14/13 --  MMRGlobal, Inc.
Dear MMRF Shareholders: 
MMRGlobal Management would like to take this opportunity to highlight
some of its accomplishments from 2012 and to share our plans for
The Company now owns seven U.S. patents and has nearly 400 claims
focused on the digital transmission of medical records, including
Personal Health Records (PHRs). The Company also has additional U.S.
patent applications pending, which include numerous continuation
applications. Internationally, the Company has issued patents and
pending applications in countries of commercial interest such as
Australia, Singapore, New Zealand, Mexico, Canada, Hong Kong, Japan,
South Korea, Israel, and European nations.  
MMR has met with significant success in our early licensing efforts
based on a five-plus year industry-wide awareness of the Company's
intellectual property and its relevance to the market. In 2013, the
Company will aggressively pursue infringement claims and plans on
commencing litigation starting this month against companies in
healthcare, retail and other markets.  
Over the last month, we have entered into licensing agreements with
EMR vendors, a laboratory reporting services vendor, a document
management systems vendor providing services to more than 750
hospitals and a Personal Health Record provider. We believe that this
trend will continue.  
Based on government regulations and the breadth of its patent
portfolio, MMR is well positioned to monetize its intellectual
property given requirements under the law pertaining to HIPAA, the
HITECH Act and Meaningful Use Stages 2 and 3. The Company believes
hospitals, healthcare professionals and certain vendors responding to
the current needs of the market will need licenses from the Company,
or they could infringe upon MMR's portfolio of intellectual property. 
The Company also anticipates receiving the next portion of milestone
payments under its $13,000,000 license agreement with a biotech
company as originally filed in a Form 8-K with the SEC on December
21, 2010. Globally, the Company will continue to exploit its biotech
IP and will retain experts in 2013 to help monetize its patents,
patient samples and other IP.  
On September 27, 2012, the Company announced the signing of an
agreement with our Australian licensee, VisiInc PLC, incorporated in
the Company's third quarter filing as Exhibit 10.1. The Agreement
calls for the sale of more than 1,000 MMRPro systems through a large
reseller of medical products and services to healthcare
professionals. As of September 30, 2012, we had delivered the first
25 MMRPro systems. Since that time, the Company is continuing
scheduled deliveries. MMRPro will be bundled with other Visi products
and marketed as VISI MMRPro, which is being sold through the Seagate
VAR and OEM channels including the Burkhart Dental channel. 
Last week, MMR participated in a demonstration of Connected Health in
the Alcatel-Lucent and ng Connect Partners booth at the International
Consumer Electronics Show. During the show, MMR demonstrated its role
as the untethered PHR to wellness solutions. The Company has been
working with Alcatel-Lucent's Connected Hospital Sales team using
MMR's PHR and portal for patients and physicians
to receive and store medical records created by Telemedicine and
Telehealth systems. We plan on deploying these services with
licensees and customers this year. As part of our Telemedicine and
Telehealth initiatives, and following MMR's attendance at the Verizon
and Alcatel-Lucent Annual Healthcare and Life Science Symposium last
November 13-14, we are continuing active discussions with Verizon and
other wireless carriers and plan on announcing strategic
relationships in 2013. The Company is also investing in building
numerous wireless interfaces to our Personal Health Record and MMRPro
professional services.  
The growth in Telemedicine will also fuel the value of the Company's
IP. Because Telemedicine portals require connectivity to the patient,
this gives MMR the opportunity to increase revenue by offering a
combined Alcatel-Lucent platform with MMR's patented PHR through
organizations and employers with direct connection to the doctor and
wellness management tools.  
The Company is also beginning to see a trend towards providing
Personal Health Records for animals. Through relationships with Pets
Best Insurance, horse owners and Dancing Paws, which I founded, we
intend to sell our PHR into the five billion dollar U.S. pet market.
We also believe that there are a number of veterinarian IT systems
providers that also infringe on the Company's patents and which we
also plan on pursuing.  
In 2012, we introduced the first Prepaid Personal Health Record card
designed for distribution in retail. This year, consumers will be
able to purchase cards nationwide.  
In 2012, MMR also entered into agreements to distribute personal
health records to seniors through home health care agencies,
retirement communities, associations, and assisted living centers.
Additionally, with the passage of the Medicare 30-Day Readmission
Rule, the Company expects to expand that initiative working with
providers and nursing associations.  
In April, our Chinese Joint Venture partner, Unis-Tongue, began
integrating a Chinese language version of our
PHR in hospitals in Henan Province. Henan Province alone has over 100
million residents. 
In 2012, MMR also received numerous patents in Mexico. As a result,
Mexico now represents an important licensing and business
opportunity. Hector V. Barreto, a former member of MMRGlobal's Board
of Directors who chairs the Company's Board of Advisors, is assisting
MMR in Mexico. Hector spent five years as Administrator of the U.S.
Small Business Administration and currently serves as Chairman of The
Latino Coalition. He also received the "Aguila Azteca" award, which
is the highest recognition bestowed by Mexico to a citizen of another
This year, the Company is planning to increase its visibility in
Washington D.C., providing a voice to the value of using stimulus
monies to fund an untethered Personal Health Record for all Americans
from the point-of-view of a small business enterprise. Meetings with
members of the Congressional Science Committee overseeing health IT
matters are being scheduled at this time.  
On behalf of MMRGlobal and its employees, may I wish you, your family
and friends the happiest, healthiest and most prosperous year as we
look forward to a great 2013. 
Robert H. Lorsch, MMRGlobal Chairman and CEO
 Follow me on Twitter at
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients in real time through an integrated patient
portal. Through its merger with Favrille, Inc. in January 2009, the
Company acquired intellectual property biotech assets that include
anti-CD20 antibodies and data and samples from its
FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit View demos and video tutorials of the
Company's products and services at 
Forward-Looking Statements 
 All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property licenses, potential intellectual
property enforcement actions, infringement claims or litigation, and
future performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from historical results or from
any results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance. Such
statements are necessarily based on assumptions and estimates and are
subject to various risks and uncertainties, including those relating
to the possible invalidity of the underlying assumptions and
estimates and possible changes or developments in economic, business,
industry, market, legal and regulatory circumstances and conditions
and actions taken or omitted to be taken by third parties, including
customers, suppliers, business partners, potential licensees,
competitors and legislative, judicial and other governmental
authorities and officials. Factors that could cause or contribute to
such differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims of
intellectual property infringement and general intellectual property
litigation; our ability to maintain, develop, monetize and protect
our patent portfolio for both the Company's health IT and
biotechnology intellectual property assets in the U.S. and
internationally; the timing of milestone payments in connection with
licensing our intellectual property; our ability to establish and
maintain strategic relationships; changes in our relationships with
our licensees; the risk the Company's products are not adopted or
viewed favorably by the healthcare community and consumer retail
market; business prospects, results of operations or financial
condition; risks related to the current uncertainty and instability
in financial and lending markets, including global economic
uncertainties; the timing and volume of sales and installations; the
length of sales cycles and the installation process; the market's
acceptance of new product and service introductions; competitive
product offerings and promotions; changes in government laws and
regulations including the 2009 HITECH Act and changes in Meaningful
Use and the 2010 Affordable Care Act; future changes in tax
legislation and initiatives in the healthcare industry; undetected
errors in our products; the possibility of interruption at our data
centers; risks related to third party vendors; risks related to
obtaining and integrating third-party licensed technology; risks
related to a security breach by third parties; risks associated with
recruitment and retention of key personnel; other litigation matters;
uncertainties associated with doing business internationally across
borders and territories; and additional risks discussed in the
Company's filings with the Securities and Exchange Commission. The
Company is providing this information as of the date of this release
and, except as required by applicable law, does not undertake any
obligation to update any forward-looking statements contained in this
release as a result of new information, future events or otherwise.  
Michael Selsman
Public Communications Co.
(310) 922-7033 
Press spacebar to pause and continue. Press esc to stop.